Progress and challenges of immunotherapy in triple-negative breast cancer
Volume: 1876, Issue: 2, Pages: 188593 - 188593
Published: Dec 1, 2021
Abstract
Triple-negative breast cancer (TNBC), a subtype of breast cancer, is defined as lacking estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) expression. Compared with other subtypes in breast cancer, TNBC is more likely to recur and metastasize, with a lower survival rate. Due to the absence of definitive targets, there was limited novel therapeutic interventions and chemotherapy remained the...
Paper Details
Title
Progress and challenges of immunotherapy in triple-negative breast cancer
Published Date
Dec 1, 2021
Volume
1876
Issue
2
Pages
188593 - 188593
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History